학술논문

Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial
Document Type
Article
Source
In The Lancet 28 October-3 November 2023 402(10412):1541-1551
Subject
Primary Research
Articles
Language
ISSN
0140-6736